Little Rock : University of Arkansas for Medical Sciences Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Duarte : City of Hope Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Irvine : UCI Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

La Jolla : University of California San Diego Moores Cancer Center (UCSD) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

La Jolla : UCSD Moores Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Los Angeles : Research Site

AMG 595 First-in-Human in Recurrent Gliomas

Los Angeles : University of California, Los Angeles

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Los Angeles : University of Southern California (USC) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Los Angeles : UCLA Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Los Angeles : UCLA Updated

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Los Angeles : UCLA Neuro-Oncology Program

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Newport Beach : Hoag Memorial Hospital Presbyterian Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Orange : St. Joseph Hospital of Orange Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Sacramento : Sutter Institute for Medical Research Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

San Diego : University of California at San Diego Updated

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

San Francisco : University of California at San Francisco

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

San Francisco : University of California at San Francisco

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

South Pasadena : South Pasadena Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Aurora : University of Colorado Denver Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Aurora : University of Colorado Denver, University of Colorado Cancer Center

Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme

Aurora : University of Colorado Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New Haven : Yale School of Medicine

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Fort Myers : Florida Cancer Specialists

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Miami Beach : Mount Sinai CCOP Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Orlando : Florida Hospital Cancer Institute

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Orlando : MD Anderson Cancer Center Orlando Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Pensacola : Woodlands Medical Specialists

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Sarasota : Florida Cancer Specialists

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor

Tampa : H. Lee Moffitt Cancer Center & Research Institute Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Tampa : Moffitt Cancer Center & Research Institute

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Savannah : Memorial University Medical Center Updated

RTOG-0913: Phase I/II Trial of Concurrent RAD001 (Everolimus) With Temozolomide/Radiation Followed by Adjuvant RAD001/Temozolomide in Newly Diagnosed Glioblastoma

Atlanta : Emory University, Winship Cancer Institute Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Chicago : Northwestern University Feinberg School of Medicine

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Chicago : University of Illinois at Chicago (UIC) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Chicago : University of Illinois Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chicago : Rush University Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chicago : Northwestern University - Robert H Lurie Comprehensive Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Peoria : Illinois Cancer Care Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Indianapolis : IU Simon Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Westwood : University of Kansas Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lexington : University of Kentucky, Markey Cancer Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Lexington : University of Kentucky - Markey Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Louisville : Norton Cancer Institute Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Scarborough : Maine Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Baltimore : The Johns Hopkins Hospital Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Bethesda : Center for Cancer and Blood Disorders

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Boston : Massachusetts General Hosptial

Amgen 386 for Recurrent Glioblastoma

Boston : Dana-Farber Cancer Institute

Amgen 386 for Recurrent Glioblastoma

Boston : Tufts Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Boston : Massachusetts General Hospital

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Boston : Dana-Farber Cancer Institute

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Boston : Tufts Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Burlington : Lahey Clinic Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Ann Arbor : University of Michigan, Department of Neurosurgery Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Detroit : Henry Ford Health Systems

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Detroit : Henry Ford Health System Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Detroit : Henry Ford Hospital

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Detroit : Henry Ford Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Detroit : Henry Ford Hospital Updated

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Minneapolis : John Nasseff Neuroscience Institute Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chesterfield : St. Louis Cancer Care

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Kansas City : St. Luke's Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

St. Louis : Washington University School of Medicine, Division of Oncology Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

St. Louis : Washington University School of Medicine Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Omaha : Nebraska Methodist Hospital

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Edison : New Jersey Neuroscience Center - JFK Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Edison : JFK Medical Center Updated

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Hackensack : John Theurer Cancer Center at Hackensack University

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Summit : Overlook Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

Manhasset : Biomedical Research Alliance of New York

If you have a brain tumor, you may be eligible to participate in a research study being conducted by North Shore-Long Island Jewish Health System.

Huntington : Huntington Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lake Success : Long Island Brain Tumor Centre at Neurological Surgery P.C. Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Lake Success : North Shore - Long Island Jewish Hospital/Monter Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Manhasset : North Shore University Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Mineola : Winthrop University Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : New York - Presbyterian/Columbia University Medical Center

Amgen 386 for Recurrent Glioblastoma

New York : Weill Cornell Medical College Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

New York : Mount Sinai Medical Center, Department of Neurosurgery Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

New York : Columbia University Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

New York : The New York Hospital/ Weill Medical College

Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma

New York : Columbia University Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : NYU Cancer Institute

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Oceanside : South Nassau Community Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rochester : University of Rochester Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rockville Centre : Mercy Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chapel Hill : University of North Carolina Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Durham : The Preston Robert Tisch Brain Tumor Center

AMG 102 and Avastin for Recurrent Malignant Glioma

Durham : Duke University Medical Center

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Winston-Salem : Derrick L Davis Forsyth Regional Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Cincinnati : Research Site

AMG 595 First-in-Human in Recurrent Gliomas

Cincinnati : University of Cincinnati

Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

Cincinnati : UC Cancer Institute Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : Cleveland Clinic

A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab for the Treatment Of Recurrent or Progressive Glioblastoma That Has Progressed on Bevacizumab

Cleveland : University Hospitals of Cleveland

A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab for the Treatment Of Recurrent or Progressive Glioblastoma That Has Progressed on Bevacizumab

Cleveland : Cleveland Clinic Taussig Cancer Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Cleveland : Cleveland Clinic Foundation Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : University Hospitals of Cleveland Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Cleveland : Cleveland Clinic Foundation Updated

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Columbus : Ohio State University Updated

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Columbus : The Ohio State University - James Comprehensive Cancer Center

Study of AR-67 in Adult Patients With Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma

Portland : Providence Cancer Center

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Portland : Oregon Health and Sciences University

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma Multiforme or Other Recurrent Malignant Gliomas

Danville : Geisinger Health System Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Danville : Geisinger Medical Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Philadelphia : Pennsylvania Hospital Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Philadelphia : Hospital of the University of Pennsylvania Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Pittsburgh : University of Pittsburgh Medical Center (UPMC) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Providence : Rhode Island Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Charleston : Medical University of South Carolina Hospitals and Clinics Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Tennessee Oncology

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Nashville : Sarah Cannon Research Institute

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor

Nashville : Vanderbilt Ingram Cancer Center Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : St. Thomas Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Nashville : Sarah Cannon Research Institute (SCRI)

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Dallas : Baylor Research Institute

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Dallas : Baylor Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Dallas : Baylor Research Institute Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Dallas : Mary Crowley Cancer Research Centers

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Houston : The University of Texas Health Science Center at Houston (UTHSC) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : Methodist Hospital Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : Methodist Neurological Institute Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Houston : Yvonne Kew, MD, PhD, Neuro-Oncology Clinic Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Houston : UT MD Anderson Cancer Center

Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)

San Antonio : Site Reference ID/Investigator# 90773

A Study Evaluating the Safety and Pharmacokinetics of ABT-414 in Subjects With Glioblastoma Multiforme in Combination With Radiation Plus Temozolomide or Temozolomide Alone

Temple : Scott and White Healthcare Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

The Woodlands : Memorial Hermann The Woodlands Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Charlottesville : University of Virginia

Amgen 386 for Recurrent Glioblastoma

Newport News : Peninsula Cancer Institute

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Richmond : Virginia Cancer Institute

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Tacoma : MultiCare Health System

A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

Seattle : Swedish Neuroscience Institute Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seattle : Swedish Hospital Neuroscience Research Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Seattle : Swedish Neuroscience Institute Updated

Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor

Parkville : Research Site

AMG 595 First-in-Human in Recurrent Gliomas

Feldkirch : Landeskrankenhaus Feldkirch

Dendritic Cell Cancer Vaccine for High-grade Glioma

Graz : University Hospital Graz Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Innsbruck : Medical University Innsbruck

Dendritic Cell Cancer Vaccine for High-grade Glioma

Linz : Landesnervenklinik Wagner-Jauregg

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Medical University Vienna

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Kaiser Franz-Josef Spital

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : Donauspital, SMZ-Ost

Dendritic Cell Cancer Vaccine for High-grade Glioma

Vienna : SMZ-Süd/Kaiser-Franz-Josef-Spital Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Vienna : Medical University of Vienna Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Calgary : Tom Baker Cancer Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Ottawa : The Ottawa Hospital Cancer Centre Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Prague : Na Homolce Hospital Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Amiens : CHU Amiens Sud-Salouel Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Angers : CHU Angers Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Bordeaux : Hôpital Saint André Centre Hospitalier Universitaire (CHU) des Hôpitaux de Bordeaux Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Lyon : Hospital of Neurology Lyon - University Claude Bernard Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Paris : Group Hospitals Pitie-Salpetriere Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Toulouse : Centre Hospitalo-Universitaire de Toulouse Purpan Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Toulouse Cedex : Institut Claudius Régaud

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Villejuif Cedex : Institut Gustave Roussy, Dept. of Medicine

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Hamburg : University Medical Center Hamburg-Eppendorf Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Heidelberg : Medical University Heidelberg Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Heidelberg : Department of Neurosurgery, University Hospital Heidelberg

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme.

Heidelberg : University of Heidelberg

Safety Study of Cetuximab, Radiotherapy and Temozolomide in Primary Glioblastoma Multiforme(GERT)

Kiel : University Hospital of Schleswig-Holstein Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Tel Aviv : Tel Aviv Sourasky Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Ancona : Az. Ospedaliero-Universitaria - Ospedali Riuniti Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Lecco : Ospedale Lecco Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Milan : Foundation Hospital Greater Policlinico Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Milan : C. Besta Neurological Institute Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Rome : Istituti Fisioterapici Ospitalieri - Istituto Nazionale dei Tumori Regina Elena Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Asan : Asan Medical Center Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Daegu : Yeungnam University Hospital Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Daejeon : Chungnam National University Hospital (CNUH) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seoul : Yonsei University Severance Hospital (YUHS) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seoul : The Catholic University of Korea, Seoul St. Mary's Hospital (CMC Seoul) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seoul : Samsung Medical Center (SMC) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seoul : Seoul National University Hospital (SNUH) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Seoul : Seoul National University Bundang Hospital (SNUBH) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Suwon : Ajou University Hospital (AUH) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Badalona : Hospital Universitari Germans Trias i Pujol Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Barcelona : Hospital Universitari de Bellvitge-ICO Duran i Reynals Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Barcelona : Hospital del Mar Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Barcelona : Hospital Clinic i Provincial de Barcelona Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Madrid : Hospital Universitario Ramon y Cajal Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Madrid : Fundacion Jimenes Diaz Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Madrid : Hospital Clinico San Carlos Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Madrid : Hospital Universitario 12 de Octubre Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Pamplona : Clínica Universidad de Navarra Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Salamanca : Hospital Universitario de Salamanca

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Seville : Servicio de Oncologia Medica Sala de Investigación

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Stockholm : Karolinska Institute Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Lausanne : Centre Hospitalier Universitaire Vaudois (CHUV) Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

Zurich : UniversitätsSpital Zürich Updated

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

London : King's College Hospital Updated

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer